| Literature DB >> 20639518 |
Laura Rienzi1, Gábor Vajta, Filippo Ubaldi.
Abstract
BACKGROUND: Non-invasive selection of developmentally competent human oocytes may increase the overall efficiency of human assisted reproduction and is regarded as crucial in countries where legal, social or religious factors restrict the production of supernumerary embryos. The purpose of this study was to summarize the predictive value for IVF success of morphological features of the oocyte that can be obtained by light or polarized microscopic investigations.Entities:
Mesh:
Year: 2010 PMID: 20639518 PMCID: PMC3001337 DOI: 10.1093/humupd/dmq029
Source DB: PubMed Journal: Hum Reprod Update ISSN: 1355-4786 Impact factor: 15.610
Figure 1Flow chart for the systematic review of the literature to investigate the predictive value of oocyte morphology in human IVF.
Summary of the results from 50 papers identified in a systematic review of the literature in order to investigate the predictive value of oocyte morphology in human IVF.
| Evaluation | Cumul | Zona | Perivit | PBshape | Oshape | Darkdifg | VacRB | Cgran | Spind. | Multiple | Remark | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F, EQ, CP, IM | − | No | No | − | No | No | No | − | − | No | ||
| CSE, BL, HA | − | No | No | − | No | No | Yes* | Yes* | − | − | *For cryosurvival | |
| ED, PL | − | − | − | − | Yes* | − | − | − | − | − | *Giant oocytes for aneuploidy | |
| F | − | Yes* ** | − | − | − | − | − | − | − | − | *Thickness (the thinner the better); **thickness variation not measured | |
| F, EQ | − | − | − | − | − | − | − | − | Yes* | − | *Presence | |
| EQ, CP, IM | − | − | Yes* | Yes* | No | + | + | + | No | Yes* ** | *For EQ; **cumulative ooplasm evaluation | |
| F, CL, CP, IM | − | − | − | No | − | − | − | − | − | − | ||
| F, CL | − | − | − | − | − | − | − | − | Yes* | − | *Presence for F | |
| ED, EQ | − | − | − | − | − | − | − | − | Yes* | *Position | ||
| F, EQ | − | − | − | No | − | − | − | No* | *Retardation | |||
| F, EQ | − | No | No | − | No | No | No | − | − | − | ||
| F, EQ | − | − | − | Yes | − | − | − | − | − | − | ||
| F, EQ, BL | − | − | − | − | (v) Yes | − | − | − | − | − | (v) Cytoplasmic viscosity | |
| F, BL | Yes* | − | − | − | − | − | − | Yes | − | − | *Blood clots in cum. | |
| F, CL, CM, BL | − | − | − | − | Yes* | − | − | − | − | − | *Ovoid: delays | |
| F, ED, CP | − | No* | − | − | − | No** | − | − | − | *Thick zona; **‘brown eggs’ | ||
| F, EQ | − | − | − | − | − | − | − | − | − | *Fragmented better large impaired | ||
| F | − | − | − | − | − | − | − | Yes* | − | *Presence and position | ||
| F, CP, IM | − | − | Yes* | − | − | − | − | − | − | − | *Coarse granules for CP and IM | |
| F, CL, CP, IM | − | − | No* | − | − | − | − | − | − | − | *Coarse dark granules | |
| EQ | − | Yes* | − | − | − | − | − | − | − | − | *Thickness variation | |
| F, EQ, CP, OP | − | − | − | − | − | − | − | Yes* | − | − | *Only OP affected | |
| CP | − | − | − | − | − | − | − | Yes* | − | *Length, retardation: yes; position: no | ||
| F, CP | − | − | − | − | − | − | − | − | Yes* | − | *Presence for CP only | |
| F, PR, THB, MB | + | + | + | + | − | + | + | − | − | No | ||
| F, CL, EQ, BL | Yes | − | − | − | − | − | − | − | − | − | ||
| F, CL, EQ, CP | − | No | − | − | − | Yes* | Yes* | − | − | − | *For EQ and CP | |
| F, CL, IM, CP | − | − | − | − | − | − | − | − | Yes* | *Presence | ||
| F, IM, CP, OP | − | Yes* | − | − | − | − | − | − | Yes** | − | *Retardation for clinical outcome; **presence | |
| F, ED, EQ | − | − | − | − | − | − | − | − | Yes* | − | *Presence + angle for EQ | |
| ED, IM, CP, THB | − | Yes* | − | − | − | − | − | − | − | − | *Inner layer retardation | |
| F, CL, EQ | − | − | − | Yes* | − | − | − | − | − | − | *Large polar body | |
| F, CL, CP | Yes* | − | − | − | − | − | − | − | − | − | *For F and CP | |
| F, CP | − | − | − | − | − | − | Yes* | − | − | − | *Smooth ER clusters for CP | |
| F, BL | − | − | − | − | − | − | Yes* | − | − | *Lipofuchsin | ||
| F, BL | − | Yes* | − | − | − | − | − | − | Yes** | − | *Thickness., retardation; **presence, retardation | |
| F, CL, CP | No | − | − | − | − | − | − | − | − | − | ||
| F, EQ | − | − | − | − | − | − | − | Yes* | − | *Presence and position for the first cleavage | ||
| PNM, F, EQ, CP | − | No | Yes | Yes | No | Yes | Yes | Yes | Yes* | *Scoring for CP THB | ||
| PL | − | − | − | − | Yes* | − | − | − | − | − | *Giant oocytes | |
| CL, EQ | Yes | − | − | − | − | − | − | − | − | − | ||
| CL, EQ, IM, CP | − | − | − | − | − | + | + | + | − | Yes* | *For IM and CP | |
| F, ED, CP | − | Yes* ** | − | − | − | − | − | − | − | − | *Inner layer retardation and thickness; **for ED and CP | |
| PNM, F, CP | − | − | − | − | − | − | − | Yes* | − | *Retardation | ||
| F, EQ | − | No | Yes* | No | No | Yes** | No | − | − | − | *Large space = better EQ; **for EQ | |
| F, EQ, BL, CP, PL | − | − | − | No | − | − | − | − | − | − | ||
| F | − | − | − | − | − | − | − | − | Yes* | − | *Presence | |
| F, ED, CP | − | − | − | − | (m) Yes* | Yes* | No | − | Yes*** | (m) Membrane properties *for F; **granulation improves outcome; ***score includes membrane properties | ||
| Xia ( | F, EQ | − | − | + | + | − | − | Yes | − | − | Yes | |
| F, CL, BL, PL | − | + | + | + | No | + | + | + | − | Yes* | *Only BL affected if multiple abnormalities |
Cumul, cumulus–oocyte complex; Zona, zona pellucida; Perivit, perivitelline space; PBshape, shape of the first polar body; Oshape, shape of the oocyte; Darkdifg, dark ooplasm or diffuse granulation; VacRB, vacuoles, inclusions, refractile bodies; Cgran, central granulation; Spind, meiotic spindle; Multiple, multiple features evaluated together (by using a scoring system). PNM, pronuclear morphology; F, fertilization; CL, cleavage; ED, embryo development; EQ, embryo quality; CSE, cryosurvival of embryos; CM, compaction; BL, development to blastrocyst stage; HA, hatching; IM, implantation; CP, clinical pregnancy; OP, ongoing pregnancy; THB, take home baby; MB, multiple birth; PL, aneuploidy. −, not investigated; +, investigated, evaluated together with other features; No, investigated, no correlation found; Yes, investigated, correlation found. Underlined, effect on outcome contradicts the majority of investigations.
Figure 2Different human oocyte morphological abnormalities (arrows) observed by light microscopy (400× magnification): (A) diffuse cytoplasmic granularity, (B) centrally located cytoplasmic granular area, (C) smooth endoplasmic reticulum clusters, (D) vacuoles, (E) abnormal zona pellucida shape, (F) large perivitelline space with fragments.
Figure 3Metaphase II human oocyte observed using polarized light microscopy (400× magnification): meiotic spindle (short arrow) and zona pellucida layers (long arrows).